Home » Topics » Regulatory » Patents

Patents
RSS

New ribose-based antibacterial agents in development at HMR

Feb. 16, 1999

Imidazole cytokine-suppressive antiinflammatory compounds from SB

Feb. 16, 1999

U.S. university researchers claim anti-HIV 2',5'-phosphorothioate/phosphodiester oligoadenylates

Feb. 15, 1999

U. of Arizona prepares novel cyanoaziridine-based antitumor agents

Feb. 15, 1999

Na+/H+ antiport inhibitors in development at Synthelabo

Feb. 15, 1999

SmithKline Beecham claims new series of inhibitors of cytokine production

Feb. 15, 1999

Novel NOS inhibitors prepared at Astra, claimed for use in inflammatory disorders

Feb. 15, 1999

New compounds from Novo Nordisk for pain, inflammation, diabetes

Feb. 12, 1999

New antiinflammatory/immunomodulatory compounds from Signal act at a transcriptional level

Feb. 12, 1999

Neurogen and Pfizer collaborate on development of NPY receptor ligands

Feb. 12, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...